Breast imaging
Case TypeClinical Cases
Authors
Dr. Sonali Sharma, Dr. Jyoti Arora, Dr. Vidhi Bakshi
Patient46 years, male
A 46-year-old male presented with a palpable left breast lump in the upper outer quadrant, present for the last two years with recent-onset local tenderness. On Physical Examination the lump was partly mobile with indistinct margins. There was no history of trauma/malignancy.
Digital Mammogram
A slightly irregular, high density mass, with micro lobulations was located in the upper outer quadrant and the reteroaereolar region of the left breast. (FIGURE 1). No associated microcalcifications, skin changes or nipple retraction were noted. The right breast was unremarkable.
Ultrasound
A slightly irregular, heterogeneously hypoechoic mass, measuring 42x18mm, with micro lobulated margins was seen in the upper outer region and the retroaereolar region of the left breast. (FIGURE 2). Moderate internal vascularity was noted. (FIGURE3). No other focal abnormality or associated gynecomastia was noted in either breast. Both axillae were unremarkable. Combined BIRADS of 4b was assigned.
A core biopsy was performed under sonographic guidance. (FIGURE 4) The histological diagnosis was that of a low-grade spindle cell lesion, favoring myofibroblastoma which was CD 34 and ER-positive (Estrogen receptor) and negative for CK (Cholecystokinin) and Desmin on Immunohistochemistry. These results were concordant with the results post excisional biopsy.
Benign breast diseases are still considered the largest cause of breast complaints.[1] Inflammatory myofibroblastic tumours (IMTs), first reported by Brunn in 1939, are rare benign tumor-like inflammatory lesions infiltrated by myofibroblasts and inflammatory cells such as lymphocytes and plasmacytes.[1] In 2002, WHO officially designated the IMT name and defined these tumors as intermediate, occasionally metastatic and locally recurrent tumours. IMTs can develop in various tissue types at all ages, with the most common sites of localisation including lung, liver, mesentery, omentum, and peritoneum.
Myofibroblastoma is a rare benign mesenchymal tumour which usually occurs in the breast parenchyma of both females and males [2]. Most cases of myofibroblastoma occur most often in women and men aged 40–87 years. It tends to affect older men and postmenopausal women [3- 6].
Coffin has classified IMTs into 3 categories: (1) myxoid pattern, or angioid type, or nodular fasciitis type; (2) dense spindle cell type or fibrous histiocytoma pattern; (3) hypocellular fibrous pattern or desmoid fibromatosis. This second category is the most common form of IMT, and the category to which our case belonged[7-10]. While mammary myofibroblastoma is pathologically classified as a benign spindle cell tumour of the mammary stroma [10,11], nonspecific imaging features at presentation necessitate tissue sampling for pathologic diagnosis.[12,13]. This was particularly true for the patient in our case, as primary breast neoplasms were also amongst the differential diagnosis. Pathologists must carefully evaluate collected specimens as immunohistochemical and morphological variants of mammary myofibroblastoma include entities resembling malignancies [12], including epithelioid and deciduoid cell variants.
Characteristically, these lesions present as a solitary, painless, firm, and freely mobile mass which grows slowly for several months or years [13,14]. An association with gynecomastia has been reported but was absent in our case. Mammography tends to demonstrate a well-circumscribed, round to oval, dense mass with rare coarse calcifications [15,16].
Sonographically, this neoplasm presents as a well-circumscribed, round to oval mass as well, with variable echogenicity [15, 17]. Thus, nonspecific imaging features necessitate tissue sampling for pathologic diagnosis. Myofibroblastoma can be treated with local excision.
Immunohistochemistry may show tumour cells are positive for CD34(cluster of differentiation 34) and desmin in approximately 89% and 91% of the cases; respectively. Tumour has been reported to be positive for BCL-2(B-cell lymphoma-2), CD99 and Smooth Muscle Actin (SMA). Other immunohistochemical markers that may aid in the diagnosis include Pan-cytokeratin and S100; both are typically negative in the neoplastic cells. (18) Our patient was positive for CD34 and ER favoring our diagnosis and negative for cytokeratin.
Written informed patient consent for publication has been obtained.
[1] Luo W, Teng P, Ni Y. (2017) A rare cardiac inflammatory myofibroblastic tumor involving aortic valve. Journal of cardiothoracic surgery. 12(1):13. (PMID: 28253894)
[2] Magro G. (2016) Mammary myofibroblastoma: an update with emphasis on the most diagnostically challenging variants. Histology and histopathology. 31(1):1-23. (PMID:26328)
[3] Magro G, Bisceglia M, Michal M, Eusebi V. (2002) Spindle cell lipoma-like tumor, solitary fibrous tumor and myofibroblastoma of the breast: a clinico-pathological analysis of 13 cases in favor of a unifying histogenetic concept. Virchows Archiv. 1;440(3):249-60. (PMID: 1188959)
[4] Reis-Filho JS, Faoro LN, Gasparetto EL, Totsugui JT, Schmitt FC. (2001); Mammary epithelioid myofibroblastoma arising in bilateral gynecomastia: case report with immunohistochemical profile. International journal of surgical pathology. 9(4):331-4. (PMID: 12574852)
[5] Magro G. (2008) Mammary myofibroblastoma: a tumor with a wide morphologic spectrum. Archives of pathology & laboratory medicine. 132(11):1813-20. (PMID: 19390423)
[6] Magro G, Salvatorelli L, Spadola S, Angelico G. (2014) Mammary myofibroblastoma with extensive myxoedematous stromal changes: a potential diagnostic pitfall. Pathology-Research and Practice. 1;210(12):1106-11. (PMID: 25242026)
[7] Magro G, Fraggetta F, Torrisi A, Emmanuele C, Lanzafame S. (1999)Myofibroblastoma of the breast with hemangiopericytoma-like pattern and pleomorphic lipoma-like areas: report of a case with diagnostic and histogenetic considerations. Pathology-Research and Practice1;195(4):257-62. (PMID: 10337665)
[8] Magro G, Michal M, Vasquez E, Bisceglia M. (2000) Lipomatous myofibroblastoma: a potential diagnostic pitfall in the spectrum of the spindle cell lesions of the breast. Virchows Archiv. 1;437(5):540-4. (PMID: 11147176)
[9] Burnside ES, Sickles EA, Bassett LW, Rubin DL, Lee CH, Ikeda DM, Mendelson EB, Wilcox PA, Butler PF, D'Orsi CJ. (2009) The ACR BI-RADS® experience: learning from history. Journal of the American College of Radiology. 1;6(12):851-60. (PMID: 19945040)
[10] Wargotz ES, Weiss SW, Norris HJ. (1987) Myofibroblastoma of the breast. Sixteen cases of a distinctive benign mesenchymal tumor. The American journal of surgical pathology. 11(7):493-502. (PMID: 3037930)
[11] Magro G. (2016) Mammary myofibroblastoma: an update with emphasis on the most diagnostically challenging variants. Histology and histopathology. 31(1):1-23. (PMID: 26328916)
[12] Omar LA, Rojanapremsuk T, Saluja K, Merchant KA, Sharma PB. (2016) Radiologic and histologic presentation of male mammary myofibroblastoma. In Baylor University Medical Center Proceedings 1 (Vol. 29, No. 3, pp. 321-322). Taylor & Francis. (PMID: 27365886)
[13] Magro G, Salvatorelli L, Spadola S, Angelico G. (2014) Mammary myofibroblastoma with extensive myxoedematous stromal changes: a potential diagnostic pitfall. Pathology-Research and Practice. 1;210(12):1106-11. (PMID: 25242026)
[14] Magro G, Gurrera A, Bisceglia M. (2003) H‐caldesmon expression in myofibroblastoma of the breast: evidence
[15] supporting the distinction from leiomyoma. Histopathology 42(3):233-8. (PMID: 12605642)
[16] Greenberg JS, Kaplan SS, Grady C. (1998) Myofibroblastoma of the breast in women: imaging appearances. AJR. American journal of roentgenology. 171(1):71-2. (PMID: 9648767)
[17] Kobayashi N, Oda K, Yokoi S, Kanda H, Hayakawa S, Tang X, Osamura Y. (1996) Myofibroblastoma of the breast: report of a case. Surgery today. 26(9):727-9. (PMID: 8883248)
[18] Dockery WD, Singh HR, Wilentz RE. (2001)Myofibroblastoma of the Male Breast: Imaging Appearance and Ultrasound‐Guided Core Biopsy Diagnosis. The breast journal. 7(3):192-4. (PMID: 11469935)
[19] Magro G. (2008) Mammary myofibroblastoma: a tumor with a wide morphologic spectrum. Archives of pathology & laboratory medicine. 132(11):1813-20. (PMID: 1897602)
URL: | https://www.eurorad.org/case/16978 |
DOI: | 10.35100/eurorad/case.16978 |
ISSN: | 1563-4086 |
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.